SCHEMBL3249118

SCHEMBL3249118

COc1ccc(-c2ccc3[nH]c(=O)c4[nH]cc(C(=O)O)c4c3c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.51
ALDH1A1 P00352 4/20 0.51
GAA P10253 3/20 0.51
POLB P06746 2/20 0.51
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
PRKAG1 P54619 4/20 0.48
PRKAA1 Q13131 4/20 0.48
PRKAB1 Q9Y478 4/20 0.48
PRKAB2 O43741 3/20 0.48
PRKAA2 P54646 3/20 0.48
PRKAG3 Q9UGI9 3/20 0.48
PRKAG2 Q9UGJ0 3/20 0.48
SMN1; SMN2 Q16637 3/20 0.46
RXFP1 Q9HBX9 1/20 0.46
GSK3A P49840 2/20 0.45
GSK3B P49841 2/20 0.45
DYRK1A Q13627 2/20 0.45
NR4A2 P43354 2/20 0.44
MMP2 P08253 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3249304 0.87 NR4A2 (0.48) KDM4ETDP1PRKAG1PRKAA1PRKAB1
SCHEMBL3250598 0.86 JAK2 (0.50) KDM4EALDH1A1GAAL3MBTL1GSK3A
SCHEMBL3250737 0.85 CYP1A2 (0.41) KDM4EPRKAG1PRKAA1PRKAB1PRKAB2
SCHEMBL3248589 0.84 PRKAG1 (0.53) PRKAG1PRKAA1PRKAB1NR4A2
SCHEMBL3244469 0.83 KDM4E (0.52) KDM4EALDH1A1GAAPOLBTDP1
SCHEMBL3248872 0.83 WEE1 (0.41) KDM4EGAANR4A2CYP1A2HSD17B10
SCHEMBL4167717 0.82 PDGFRB (0.49) KDM4EALDH1A1GAAPOLBTDP1
SCHEMBL3247723 0.82 FASN (0.42) PRKAG1PRKAA1PRKAB1PRKAB2PRKAA2
SCHEMBL3255249 0.81 BRD4 (0.60) KDM4EALDH1A1GAAPOLBSMN1; SMN2
SCHEMBL3249048 0.81 POLB (0.54) KDM4EALDH1A1GAAPOLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899335-B1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PF MEDICAMENT (FR) 2010-05-19 EP claimed
EP-1899335-A1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PIERRE FABRE MEDICAMENT (FR) 2008-03-19 EP claimed
WO-2007003611-A1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PIERRE FABRE MEDICAMENT (FR) 2007-01-11 WO claimed
EP-1899335-B1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PF MEDICAMENT (FR) 2010-05-19 EP disclosed
EP-1899335-A1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PIERRE FABRE MEDICAMENT (FR) 2008-03-19 EP disclosed
WO-2007003611-A1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PIERRE FABRE MEDICAMENT (FR) 2007-01-11 WO disclosed